drugset / Trial / NCT04494243
A Study to Compare PK, PD and Safety of the AD-214 10/600mg and Rabeprazole
RandomizedCrossoverOpen-labelTreatment
Summary
A study to compare safety, pharmacokinetics and pharmacodynamics of AD-214 10/600mg to Rabeprazole 10mg in healthy volunteers.
Timeline
- Start
- 2020-08-28
- Primary completion
- 2021-01-15
- Completion
- 2021-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-214 | Protein / enzyme biologic | — | — |
| Subject | Rabeprazole | Small molecule | 10 mg | — |